Navigation Links
Financial Incentives Could Improve Organ Donation and Reduce Donor-Recipient Gap
Date:6/16/2008

CHICAGO, June 16 /PRNewswire-USNewswire/ -- Today, the AMA adopted policy calling for the modification of current law to allow pilot studies on financial incentives for cadaveric organ donation. The current law, the National Organ Transplantation Act, prohibits financial incentives for organ donation, stating that any motivation for donation other than altruism is unethical. The AMA already supports study into financial incentives for cadaveric organ donation.

"Today there are nearly 100,000 patients waiting for organ transplants of all types, and that number continues to grow," said AMA Board Member Joseph Annis, M.D. "Exploring all ethical ways to increase the number of organ donations may save lives that may otherwise be tragically lost. Voluntary organ donation remains important, but motivational incentives that could increase organ donations -- including financial incentives -- must be studied."


'/>"/>
SOURCE American Medical Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. China Yingxia International, Inc. Appoints Chief Financial Officer
2. Chem Rx Corporation Appoints Gary M. Jacobs Chief Financial Officer
3. Alphatec Spine Names New Chief Financial Officer
4. Robbins & Myers Schedules Third Quarter Fiscal 2008 Financial Results Conference Call
5. China Medical Technologies Reports Fourth Quarter and Full Year Financial Results
6. Bridges to Excellence Study Assesses Clinical and Financial Impact of Physician Quality Measures
7. Chem Rx Corporation Reports First Quarter 2008 Financial Results
8. Employer Use of Financial Incentives to Reward Healthy Behavior Expected To Surge
9. Conseco Declines Proposal from Steel Partners II, L.P.; Proposal Would Reduce Consecos Financial Flexibility and Potentially Disadvantage Other Shareholders
10. PartnerRe Executive Vice President & Chief Financial Officer Albert Benchimol to Present at the FPK CCW Credit Risk Conference in London on June 6, 2008
11. Lincoln Financial Group Launches Lincoln 403(b)e SURE(SM) Advantage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... DC (PRWEB) , ... May 26, 2016 , ... There ... National Hot Dog and Sausage Council (NHDSC) suggests that Americans prefer their dogs straight ... dogs, 63 percent say grilling is their favorite way to cook a hot dog, ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... discovery of thousands of defective respirators, according to court documents and SEC filings. ... of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University ... specialty academic programs. , Answering to the increasing demand for curricular specializations, the ... law, and environmental and land use law. ,  , “The demand for lawyers ...
(Date:5/26/2016)... ... ... On Memorial Day, Hope For Heroes and USA Medical Card will ... country. The nonprofit Hope For Heroes partnered with the leading provider of free ... military veterans, as well as police, firemen, and EMS professionals across the country, and ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... 25,2016 FDA 510(k) clearance ... platform for urological and surgical applications ... of Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) ... the US with the 12 th 510(k) ... (FDA). This new FDA clearance covers Confocal Miniprobes ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: